EGFR and neoplasm: We detected strong specific immunoreactivity in tumor cells of the 3 tumors which had RNA-overexpression for EGFR, MET and CDK6. On the contrary, none of the 3 tumors which were normally expressed for EGFR, MET and CDK6 mRNA were considered IHC positive.